Aims To determine the effectiveness of 2 weeks' pre‐cessation nicotine patches and/or gum
on smoking abstinence at 6 months. Design Pragmatic randomized controlled trial. Setting …

Importance The US Food and Drug Administration adopted labeling for nicotine patches to
allow use beyond the standard 8 weeks. This decision was based in part on data showing …

Objectives: There is a critical need for the development of novel treatments for nicotine
dependence. Because the majority of smokers who make a quit attempt fail within 7 days …

Background Nonadherence to smoking cessation medication is a frequent problem.
Identifying pre-quit predictors of nonadherence may help explain nonadherence and …

Aims Smoking cessation treatment trials often require that smokers quit on or before a
protocol‐defined date. The goals of this paper were to:(1) identify factors associated with …

Objective: To assess if the effect of a single treatment episode with nicotine replacement
therapy (NRT) enhances smoking cessation over many years. Data sources: Meta-analysis …

Abstract The Medication Adherence Questionnaire (MAQ) is a scale used to evaluate
adherence to medications. The present study assessed the factor structure and validity of the …

Background and aims Although smoking cessation medications have shown effectiveness in
increasing abstinence in randomized controlled trials (RCTs), it is unclear to what extent …

Background Transdermal nicotine, with behavioral counseling, is among the most popular
approaches used to quit smoking. Yet, 6-month cessation rates rarely exceed 20–25 …

Most clinical trials use 6 months or 1 year follow-ups as proxies for life-time smoking
cessation. Retrospective studies have estimated 2–15% of smokers relapse each year after …